Vērtējums:
Publicēts: 01.12.1996.
Valoda: Angļu
Līmenis: Vidusskolas
Literatūras saraksts: Nav
Atsauces: Nav
  • Eseja 'Pfizer: An Economic Report', 1.
  • Eseja 'Pfizer: An Economic Report', 2.
  • Eseja 'Pfizer: An Economic Report', 3.
  • Eseja 'Pfizer: An Economic Report', 4.
  • Eseja 'Pfizer: An Economic Report', 5.
  • Eseja 'Pfizer: An Economic Report', 6.
  • Eseja 'Pfizer: An Economic Report', 7.
Darba fragmentsAizvērt

1. Introduction
The world is changing all around us. In order to stay ahead of this every changing economy, it is important to proactively seek out operations that are better, faster and cheaper. As large pharmaceutical companies become larger pharmaceutical companies through the merger and acquisition of the competition, the dynamics of the company must be accounted for. Companies are becoming more cost focused to ensure the return on investment of developing new pharmaceutical drugs in the Twentieth Century. An example of cost savings is shipping manufacturing plants offshore. This…

Atlants